Was rather hoping Suzi et al would get it down a bit more to hit my added buy targets, but I guess not.
Looking forward to when they get the mfg moves done. Will be a nice boost there in earnings once the high overseas tax rates are avoided.
new short interest number today, for end of March: 1,384,486 . Some folks soiled themselves with today's pop up. Those folks must have dug a really deep hole under themselves, as they didn't see fit to cover when they could have. Just means more guaranteed buyers.
Also saw in the news that the FDA approved B&L's toric IOL. That FDA arm seems to meet very little and do little, so it is interesting to see they are doing something. About time!
I read parts of the FDA staff report that went to the panel (highly technical and I can't pretend to understand it all). It is essentially an improved and toric version of the Crystalens. My impression was that the staff was extremely cautious and kind of negative, compared to the overwhelming panel votes in favor (unanimous on safety, 10-1 on effectiveness).
I believe Staar submitted a new Toric ICL study in November. Doesn't that mean it should get a PDUFA response in 180 days, meaning in May? Staar's potential would be so much greater if it could get the TICL approved and then the v4c.